News & Updates

Adagrasib shows antitumour activity in KRAS G12C-mutant colorectal cancer
Adagrasib shows antitumour activity in KRAS G12C-mutant colorectal cancer
07 Jan 2023

Adagrasib appears to have some effect against metastatic, KRAS G12C-mutated colorectal cancer when used in treatment-experienced patients either as oral monotherapy or in combination with cetuximab, according to the results of a phase I-II, open-label study.

Adagrasib shows antitumour activity in KRAS G12C-mutant colorectal cancer
07 Jan 2023
Cardiovascular, mortality outcomes in hypertension similar between two thiazide diuretics
Cardiovascular, mortality outcomes in hypertension similar between two thiazide diuretics
06 Jan 2023

The use of chlorthalidone in the treatment of patients with hypertension does not appear to provide better protection against major cardiovascular outcome events or noncancer-related deaths when compared with hydrochlorothiazide, according to a study.

Cardiovascular, mortality outcomes in hypertension similar between two thiazide diuretics
06 Jan 2023